What is the management of a patient with ruptured esophageal varices?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Ruptured Esophageal Varices

Ruptured esophageal varices require immediate resuscitation with restrictive transfusion (target hemoglobin 7-9 g/dL), simultaneous initiation of vasoactive drugs (terlipressin preferred, or octreotide if unavailable) and antibiotics (ceftriaxone 1g IV daily), followed by urgent endoscopic variceal ligation within 12 hours. 1, 2

Immediate Resuscitation (First 30 Minutes)

  • Secure the airway in patients with active hematemesis or altered mental status to prevent aspiration 1
  • Establish large-bore IV access and transfer to ICU or monitored setting given high mortality risk 2
  • Use restrictive transfusion strategy targeting hemoglobin 7-9 g/dL - overtransfusion increases portal pressure and worsens rebleeding 1, 2
  • Avoid aggressive crystalloid resuscitation as this precipitates rebleeding through increased portal pressure 2
  • Consider fresh frozen plasma and platelets only in patients with significant coagulopathy/thrombocytopenia 3

Critical Pitfall: Do NOT overtransfuse beyond hemoglobin 8 g/dL, as this increases portal pressure and rebleeding risk 1

Pharmacological Therapy (Start Immediately, Before Endoscopy)

Vasoactive Drugs (Initiate on Clinical Suspicion)

Terlipressin is the preferred agent due to proven 34% mortality reduction (RR 0.66,95% CI 0.49-0.88) 1:

  • Continuous infusion: 4 mg/24 hours (superior hepatic venous pressure gradient reduction and lower rebleeding) 1
  • Alternative bolus dosing: 2 mg IV every 4 hours initially, then titrate to 1 mg IV every 4 hours once controlled 1
  • Continue for 2-5 days after diagnosis confirmation 1, 3
  • Contraindications: Active coronary/peripheral/mesenteric ischemia, hypoxia, worsening respiratory symptoms, pregnancy 1

If terlipressin unavailable, use octreotide 1, 3:

  • 50 µg IV bolus followed by continuous infusion of 50 µg/hour 1
  • Continue for 3-5 days 3

Alternative: Somatostatin 250 µg IV bolus followed by 250 µg/hour infusion 1

Critical Pitfall: Do NOT delay vasoactive drugs waiting for endoscopy - start immediately upon clinical suspicion 1

Critical Pitfall: Do NOT use non-selective beta-blockers during acute bleeding, as they decrease blood pressure and blunt compensatory tachycardia 2

Antibiotic Prophylaxis (Mandatory)

  • Ceftriaxone 1g IV daily for maximum 7 days (preferred in advanced cirrhosis and centers with quinolone resistance) 3, 1, 2
  • Alternative: Norfloxacin 400 mg PO BID or IV ciprofloxacin if oral not possible 3
  • Antibiotics reduce mortality, bacterial infections, and rebleeding 1, 2

Endoscopic Management (Within 12 Hours)

  • Perform urgent endoscopy within 12 hours once hemodynamically stabilized 3, 1, 2
  • Endoscopic variceal ligation (EVL) is first-line therapy, achieving hemostasis in approximately 90% of cases 4, 2
  • EVL is superior to sclerotherapy with better safety profile 1
  • Combination of EVL plus vasoactive drugs is superior to either alone, reducing very early rebleeding and treatment failure 4
  • Consider proton pump inhibitor (pantoprazole 40 mg IV then 40 mg PO daily for 9 days) after EVL to reduce post-ligation ulcer size 3

Rescue Therapy for Treatment Failure (10-20% of Patients)

Balloon Tamponade (Temporary Bridge Only)

  • Use as temporizing measure for maximum 24 hours in uncontrollable bleeding while arranging definitive therapy 3, 1, 2
  • Alternative: Removable covered self-expanding esophageal stents 1

Early TIPS (Definitive Rescue)

Early TIPS (within 24-72 hours, ideally <24 hours) is indicated for 1, 4:

  • Failure to control bleeding with combined pharmacological and endoscopic therapy 3
  • High-risk patients:
    • Child-Pugh class B with active bleeding at endoscopy 1, 4
    • Child-Pugh class C with MELD score <14 1, 4
    • Hepatic venous pressure gradient (HVPG) ≥20 mmHg measured within 24 hours 1, 4
  • TIPS achieves 90-100% hemostasis in rescue settings but carries 15-25% risk of hepatic encephalopathy 4

Special Considerations for Gastric Varices

  • Type 1 gastric varices (GOV1) along lesser curvature: Manage identically to esophageal varices with EVL 1, 4
  • Fundal varices (GOV2, IGV1): Use endoscopic variceal obturation with cyanoacrylate injection rather than EVL 1, 4
    • Cyanoacrylate achieves better control (94% vs 80%) and lower rebleeding (23% vs 47%) compared to EVL 4
  • Isolated splenic vein thrombosis: Treat with splenectomy 1, 4

Post-Acute Management (Before Discharge)

  • Start non-selective beta-blocker once recovered from acute bleeding and before discharge 2
  • Combine with repeat EVL sessions every 2-8 weeks until variceal eradication (usually 2-4 sessions) 3, 2
  • This combination reduces rebleeding to 14-23% versus 38-47% with EVL alone 2
  • Refer to transplant center if Child-Pugh score ≥7 or MELD score ≥15 3

Key Algorithmic Approach

  1. Immediate (0-30 min): Airway protection + IV access + restrictive transfusion (Hgb 7-9) + ICU transfer
  2. Simultaneous (0-30 min): Start terlipressin (or octreotide) + ceftriaxone 1g IV
  3. Within 12 hours: Urgent EGD with EVL
  4. Continue: Vasoactive drugs 2-5 days, antibiotics maximum 7 days
  5. If failure: Early TIPS within 24-72 hours for high-risk patients or uncontrolled bleeding
  6. Before discharge: Start beta-blocker + schedule repeat EVL sessions

References

Guideline

Management of Oesophageal Varices Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Acute Esophageal Variceal Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Esophageal Varices and Gastric Varices

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can cigar smoking worsen esophageal varices?
What is the best course of action for a patient presenting with right foot pain, redness, and poor blood return, with varices in both legs, who has been using overly tight compression socks?
What's the next step in managing a hemodynamically stable adult patient with hepatitis C and cirrhosis, presenting with acute upper GI (Gastrointestinal) bleeding due to large esophageal varices, after initial stabilization with IV (Intravenous) octreotide, PPI (Proton Pump Inhibitor), and antibiotics, and application of variceal band ligation?
What is the best long-term intervention to decrease the risk of recurrent variceal bleeding in an elderly patient with a history of liver cirrhosis and esophageal varices who has undergone endoscopic variceal ligation?
What is the best next step in managing a patient with a history of cirrhosis and esophageal varices who presents with a brief episode of hematemesis that has since stopped?
What are the most common bacteria responsible for pneumonia in an immunocompromised patient?
What are the sources of collagen similar to marine collagen?
What is the cause of my chronic neuropathic pain, which started in my heels, then affected my tibial nerve, and is accompanied by tightness in my calf and hamstring, occasional lower back pain, and constant upper back muscle soreness extending to my biceps, forearms, wrists, and fingers, which feel tingly?
What bacteria are likely to cause pneumonia with pneumomediastinum in an immunocompromised patient?
What is the best surgical approach for a fistula in a patient with pre-existing pudendal (nerve) neuropathy due to straining on the toilet?
What is the best treatment approach for a patient with Community-Acquired Pneumonia (CAP) and methicillin-resistant Staphylococcus aureus (MRSA) infection who develops acute kidney injury (AKI)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.